Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Protecting Against Unique Claims Regarding Medical Device Sales Reps

By Lori Cohen and Christiana C. Jacxsens
January 29, 2009

In recent years, pharmaceutical and medical device manufacturers have faced an increased number of creative product liability claims arising from alleged actions of their sales representatives. Medical device manufacturers may face a challenge in preventing these claims because of the unique role of these representatives. Medical device sales representatives, as compared with pharmaceutical sales representatives, may be present during patient-physician visits to provide technical support for the device or instrumentation. This distinct role makes medical device manufacturers susceptible to allegations that the sales representative somehow improperly inserted herself or himself into the patient-physician relationship or otherwise affected patient care. Unlike cases involving allegations regarding pharmaceutical sales representatives, there are few rulings in cases with claims involving medical device sales representatives. Further, it is unclear what the effect of the recent U.S. Supreme Court opinion in Riegel v. Medtronic, 128 S. Ct. 999 (2008), will be on these claims. Although this is a developing area of the law, recent court decisions can provide medical device manufacturers with some insight into pertinent training topics for its sales force, in order to protect against these types of claims.

The Learned Intermediary Doctrine

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

A Lawyer's System for Active Reading Image

Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.

Bankruptcy Sales: Finding a Diamond In the Rough Image

There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.